Richard F. LeBlond, MD
To the Editor: The editors are to be congratulated for encouraging the use of a rational, standardized format for abstracts. I would like to propose a further step toward clear and standard reporting: expression of benefits and morbidity in terms of the entire group treated, the only prospectively identifiable denominator. In this way true comparisons of benefit and morbidity can be made. Many large controlled trials present benefits as percentage change in relative risk and morbidity as raw percentage of the total group treated. This form of presentation creates an exaggerated sense of benefit and diminishes the apparent magnitude of
LeBlond RF. Improving Structured Abstracts. Ann Intern Med. ;111:764. doi: 10.7326/0003-4819-111-9-764_1
Download citation file:
Published: Ann Intern Med. 1989;111(9):764.
Copyright © 2018 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use